Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keeton

Showing results (511-520 of 547) with videos related to

Pageof 55
Sort By:
Child and Adolescent Psychiatry and Mental Health|August 17, 2013
Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methodsGloria M Reeves, Courtney Keeton, Christoph U Correll, et al.
Cell Host & Microbe|January 11, 2024
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variantRofhiwa Nesamari, Millicent A Omondi, Richard Baguma, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2026
Targeting phosphodiesterase 10A disrupts MAPK signaling pathways in the tumor microenvironment to unleash antitumor immunityMd Y Gazi, Yan Ye, Ogacheko D Okoko, et al.
Journal of Consulting and Clinical Psychology|January 15, 2014
Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trialScott N Compton, Tara S Peris, Daniel Almirall, et al.
Blood|December 24, 2013
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemiaErika K Keeton, Kristen McEachern, Keith S Dillman, et al.
Oncogene|April 8, 2014
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activityN Li, K Lee, Y Xi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Distinct and convergent effects of <i>SF3B1</i> mutations in human breast cancerRiley E Bergman, Christin I Keeton, Irika R Sinha, et al.
Clinical Immunology (Orlando, Fla.)|December 23, 2023
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell responseClaire Butters, Ntombi Benede, Thandeka Moyo-Gwete, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Cell Host & Microbe|February 13, 2015
The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunityGillian J Wilson, Mohlopheni J Marakalala, Jennifer C Hoving, et al.
Pageof 55

Showing results (511-520 of 547) with videos related to

Sort By:
Pageof 55
Child and Adolescent Psychiatry and Mental Health|August 17, 2013
Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methodsGloria M Reeves, Courtney Keeton, Christoph U Correll, et al.
Cell Host & Microbe|January 11, 2024
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variantRofhiwa Nesamari, Millicent A Omondi, Richard Baguma, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2026
Targeting phosphodiesterase 10A disrupts MAPK signaling pathways in the tumor microenvironment to unleash antitumor immunityMd Y Gazi, Yan Ye, Ogacheko D Okoko, et al.
Journal of Consulting and Clinical Psychology|January 15, 2014
Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trialScott N Compton, Tara S Peris, Daniel Almirall, et al.
Blood|December 24, 2013
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemiaErika K Keeton, Kristen McEachern, Keith S Dillman, et al.
Oncogene|April 8, 2014
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activityN Li, K Lee, Y Xi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Distinct and convergent effects of <i>SF3B1</i> mutations in human breast cancerRiley E Bergman, Christin I Keeton, Irika R Sinha, et al.
Clinical Immunology (Orlando, Fla.)|December 23, 2023
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell responseClaire Butters, Ntombi Benede, Thandeka Moyo-Gwete, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Cell Host & Microbe|February 13, 2015
The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunityGillian J Wilson, Mohlopheni J Marakalala, Jennifer C Hoving, et al.
Pageof 55